The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | J | Antiinfectives for systemic use | |
2 | J01 | Antibacterials for systemic use | |
3 | J01D | Other beta-lactam antibacterials | |
4 | J01DC | Second-generation cephalosporins |
Code | Title | |
---|---|---|
J01DC01 | Cefoxitin | |
J01DC02 | Cefuroxime | |
J01DC03 | Cefamandole | |
J01DC04 | Cefaclor | |
J01DC05 | Cefotetan | |
J01DC06 | Cefonicide | |
J01DC07 | Cefotiam | |
J01DC08 | Loracarbef | |
J01DC09 | Cefmetazole | |
J01DC10 | Cefprozil | |
J01DC11 | Ceforanide | |
J01DC12 | Cefminox | |
J01DC13 | Cefbuperazone | |
J01DC14 | Flomoxef | |
J01DC52 |
Active Ingredient | Description | |
---|---|---|
Cefaclor |
Cefaclor is a second-generation cephalosporin antibiotic. Cefaclor has no activity against Pseudomonas species or Acinetobacter species. Methicillin-resistant staphylococci and most strains of enterococci (eg, Str. faecalis) are resistant to cefaclor. |
|
Cefamandole |
|
|
Cefminox |
|
|
Ceforanide |
|
|
Cefotetan |
Cefotetan is a bactericidal agent that acts by inhibition of bacterial cell wall synthesis. Cefotetan has activity in the presence of some beta-lactamases, both penicillinases and cephalosporinases, of gram-negative and gram-positive bacteria. |
|
Cefoxitin |
Cefoxitin is a beta-lactam antibiotic of the group of the second-generation cephalosporins. |
|
Cefprozil |
Cefprozil is a semi synthetic broad-spectrum cephalosporin antibiotic intended for oral administration. The bactericidal action of cefprozil results from inhibition of cell-wall synthesis. |
|
Cefuroxime |
Cefuroxime inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs). This results in the interruption of cell wall (peptidoglycan) biosynthesis, which leads to bacterial cell lysis and death. |
|
Flomoxef |
|
|
Loracarbef |
|
Title | Information Source | Document Type | |
---|---|---|---|
AXETINE Film-coated tablet | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
AXETINE Powder for solution for injection / infusion | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
CECLOR Granules | Medicines Authority (MT) | MPI, EU: SmPC | |
CEROXIM Tablet, Suspension | Health Products Regulatory Authority (ZA) | MPI, Generic | |
DISTACLOR Capsule | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
MEDOCLOR Hard capsule, Granules for oral suspension | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
RENOXITIN Powder for solution for injection / infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
SYNTOCLOR Hard capsule | Υπουργείο Υγείας (CY) | MPI, EU: SmPC | |
ZINACEF Powder for injection / infusion | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
ZINNAT Film-coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |